Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1888 1
1890 2
1891 1
1894 2
1896 5
1898 1
1899 1
1901 1
1907 1
1908 1
1928 1
1950 2
1951 1
1952 1
1953 1
1954 1
1958 1
1961 2
1962 2
1963 4
1964 3
1965 7
1966 10
1967 4
1968 4
1969 1
1970 7
1971 5
1972 8
1973 10
1974 8
1975 4
1976 6
1977 6
1978 2
1979 2
1980 6
1981 6
1982 5
1983 11
1984 2
1985 9
1986 8
1987 5
1988 16
1989 14
1990 19
1991 18
1992 29
1993 19
1994 28
1995 19
1996 12
1997 7
1998 15
1999 21
2000 19
2001 29
2002 35
2003 36
2004 57
2005 44
2006 99
2007 90
2008 84
2009 118
2010 101
2011 122
2012 157
2013 110
2014 136
2015 134
2016 124
2017 120
2018 106
2019 100
2020 143
2021 153
2022 149
2023 153
2024 171
2025 195

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,855 results

Results by year

Filters applied: . Clear all
Page 1
Linking emotional valence and anxiety in a mouse insula-amygdala circuit.
Nicolas C, Ju A, Wu Y, Eldirdiri H, Delcasso S, Couderc Y, Fornari C, Mitra A, Supiot L, Vérité A, Masson M, Rodriguez-Rozada S, Jacky D, Wiegert JS, Beyeler A. Nicolas C, et al. Among authors: mitra a. Nat Commun. 2023 Aug 21;14(1):5073. doi: 10.1038/s41467-023-40517-1. Nat Commun. 2023. PMID: 37604802 Free PMC article.
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.
Wang ES, Issa GC, Erba HP, Altman JK, Montesinos P, DeBotton S, Walter RB, Pettit K, Savona MR, Shah MV, Kremyanskaya M, Baer MR, Foran JM, Schiller G, Adès L, Heiblig M, Berthon C, Peterlin P, Rodríguez-Arbolí E, Salamero O, Patnaik MM, Papayannidis C, Grembecka J, Cierpicki T, Clegg B, Ray J, Linhares BM, Nie K, Mitra A, Ahsan JM, Tabachri M, Soifer HS, Corum D, Leoni M, Dale S, Fathi AT. Wang ES, et al. Among authors: mitra a. Lancet Oncol. 2024 Oct;25(10):1310-1324. doi: 10.1016/S1470-2045(24)00386-3. Lancet Oncol. 2024. PMID: 39362248 Clinical Trial.
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer.
Foote JB, Mattox TE, Keeton AB, Chen X, Smith F, Berry KL, Holmes T, Wang J, Huang CH, Ward AB, Mitra AK, Ramirez-Alcantara V, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Nagaraju GP, Bandi DSR, Maxuitenko YY, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou G, Nurmemmedov E, Babic I, Gaponenko V, Abdelkarim H, Boyd MR, Gorman GS, Manne U, Bae S, El-Rayes BF, Piazza GA. Foote JB, et al. Among authors: mitra ak. bioRxiv [Preprint]. 2024 Oct 7:2023.05.17.541233. doi: 10.1101/2023.05.17.541233. bioRxiv. 2024. Update in: Cancer Res. 2025 Mar 03;85(5):956-972. doi: 10.1158/0008-5472.CAN-24-0323. PMID: 38328254 Free PMC article. Updated. Preprint.
Mechanisms of Action of TMS in the Treatment of Depression.
Downar J, Siddiqi SH, Mitra A, Williams N, Liston C. Downar J, et al. Among authors: mitra a. Curr Top Behav Neurosci. 2024;66:233-277. doi: 10.1007/7854_2024_483. Curr Top Behav Neurosci. 2024. PMID: 38844713 Review.
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.
Foote JB, Mattox TE, Keeton AB, Chen X, Smith FT, Berry K, Holmes TW, Wang J, Huang CH, Ward A, Mitra AK, Ramirez-Alcantara V, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Nagaraju GP, Bandi DSR, Maxuitenko YY, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou G, Nurmemmedov E, Babic I, Gaponeko V, Abdelkarim H, Boyd MR, Gorman G, Manne U, Bae S, El-Rayes BF, Piazza GA. Foote JB, et al. Among authors: mitra ak. Cancer Res. 2025 Mar 3;85(5):956-972. doi: 10.1158/0008-5472.CAN-24-0323. Cancer Res. 2025. PMID: 39700396 Free PMC article.
Optimized ultrasound neuromodulation for non-invasive control of behavior and physiology.
Murphy KR, Farrell JS, Bendig J, Mitra A, Luff C, Stelzer IA, Yamaguchi H, Angelakos CC, Choi M, Bian W, DiIanni T, Pujol EM, Matosevich N, Airan R, Gaudillière B, Konofagou EE, Butts-Pauly K, Soltesz I, de Lecea L. Murphy KR, et al. Among authors: mitra a. Neuron. 2024 Oct 9;112(19):3252-3266.e5. doi: 10.1016/j.neuron.2024.07.002. Epub 2024 Jul 29. Neuron. 2024. PMID: 39079529 Free PMC article.
Editorial Comment.
Mitra AP. Mitra AP. J Urol. 2024 Feb;211(2):252-253. doi: 10.1097/JU.0000000000003778.02. Epub 2024 Feb 1. J Urol. 2024. PMID: 38193405 No abstract available.
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Somaiah N, et al. Among authors: mitra a. Lancet Oncol. 2022 Sep;23(9):1156-1166. doi: 10.1016/S1470-2045(22)00392-8. Epub 2022 Aug 4. Lancet Oncol. 2022. PMID: 35934010 Clinical Trial.
2,855 results